Brent has over 25 years of experience in various aspects of healthcare and has been in leadership roles at several prominent global pharmaceutical and healthcare companies. Until May 2020, when it was acquired by AbbVie Inc. in a transaction valued at approximately $63 billion, Brent served as Chairman, President and Chief Executive Officer of Allergan plc. His role as President and Chief Executive Officer of Allergan began in July 2014 and his added role of Chairman began in October 2016. Brent’s first role as an executive officer in the pharmaceuticals and healthcare sectors began in 2003, as a member of the executive management team at Schering-Plough Corporation, where he held several key roles, including President of the company’s Global Consumer Health Care division. While at Schering-Plough, Brent led the integrations of the company’s $14 billion acquisition of Organon Biosciences N.V in 2007 as well as the merger between Schering-Plough and Merck & Co., Inc. in 2009. From March 2010 until August 2013, Brent served as Chief Executive Officer of Bausch + Lomb Incorporated, a leading global eye health company, until its acquisition by Valeant Pharmaceuticals, Inc. in 2013. He then became the Chief Executive Officer of Forest Laboratories Inc., a role he held until the company’s merger with Actavis plc in 2014. Following the merger with Actavis, Brent was named Chief Executive Officer of the combined business. In 2015, he led Actavis’ acquisition of Allergan, renaming the combined company Allergan Plc.
Before joining Schering-Plough in 2003, Brent was a Partner and Head of Compliance Business Advisory at PricewaterhouseCoopers LLP. Prior to that, he was Chief Risk Officer at Coventry Health Care, Inc. and Senior Vice President, Compliance, Legal and Regulatory at Home Care Corporation of America. Brent began his career as Chief Compliance Officer for the Thomas Jefferson University Health System.
Brent currently serves as Chairman and CEO of Bausch + Lomb Corporation.
What is Brent L. Saunders' net worth?
The estimated net worth of Brent L. Saunders is at least $1.14 million as of May 22nd, 2025. Saunders owns 719,156 shares of Beauty Health stock worth more than $1,136,266 as of December 5th. This net worth approximation does not reflect any other investments that Saunders may own. Learn More about Brent L. Saunders' net worth.
How do I contact Brent L. Saunders?
The corporate mailing address for Saunders and other Beauty Health executives is 1819 West Avenue Bay 2, Miami Beach FL, 33139. Beauty Health can also be reached via phone at 800-603-4996 and via email at https://investors.beautyhealth.com. Learn More on Brent L. Saunders' contact information.
Has Brent L. Saunders been buying or selling shares of Beauty Health?
Brent L. Saunders has not been actively trading shares of Beauty Health within the last three months. Most recently, on Monday, August 12th, Brent L. Saunders bought 40,450 shares of Beauty Health stock. The stock was acquired at an average cost of $1.08 per share, with a total value of $43,686.00. Following the completion of the transaction, the chairman now directly owns 5,921,769 shares of the company's stock, valued at $6,395,510.52. Learn More on Brent L. Saunders' trading history.
Who are Beauty Health's active insiders?
